Hennekam Lymphangiectasia-Lymphedema syndrome 1 (HKLLS1)

Was ist Hennekam Lymphangiectasia-Lymphedema syndrome 1 (HKLLS1)?

Hennekam syndrome is a rare disease which affects the lymphatic system. The lymphatic system also involves the circulatory and immune systems. It is what transports immune and lymph cells around the body.

Symptoms and life expectancy with the syndrome can vary widely between patients, including those within the same family. Some patients survive into adulthood. There are currently 50 cases of the syndrome reported worldwide. The syndrome is usually recognized at birth.

This syndrome is also known as:
Hennekam Lymphangiectasia-lymphedema Syndrome Hennekam syndrome Lymphatic Dysplasia, Generalized

Was Genveränderungen verursachen Hennekam Lymphangiectasia-Lymphedema syndrome 1 (HKLLS1)?

Es wird durch Mutationen in den CCBE1-, FAST4- oder ADAMTS3-Genen verursacht. Das Hennekam-Syndrom wird autosomal-rezessiv vererbt.

Autosomal-rezessive Vererbung bedeutet, dass eine betroffene Person von jedem ihrer Elternteile eine Kopie eines mutierten Gens erhält, wodurch sie zwei Kopien eines mutierten Gens erhält. Eltern, die nur eine Kopie der Genmutation tragen, zeigen im Allgemeinen keine Symptome, haben jedoch eine 25% ige Chance, die Kopien der Genmutationen an jedes ihrer Kinder weiterzugeben.

Was sind die wichtigsten symptome von Hennekam Lymphangiectasia-Lymphedema syndrome 1 (HKLLS1)?

Lymphangiectasia, or lymph vessels that are swollen, is the most common symptom of Hennekam syndrome. This tends to affect most severely the vessels that carry lymph cells to and from the intestines. This can also affect the skin, kidneys and heart of an affected individual or patient.

Another main symptom is Lymphedema, which is a build up of fluid in the body that causes puffiness and swelling.

Unique facial features include a flattened middle part of the face, puffy eyelids, widely-spaced eyes, small ears and mouth. A small head and premature fusing of the skull bones are also recognized features of Hennekam syndrome.

Other features include mild to severe intellectual disability, anemia (a shortage of red blood cells), multiple spleens, misplaced kidneys, genital abnormalities and umbilical hernia. Excessive body hair, scoliosis and clubfoot are also recognized as symptoms of the disease.

Possible clinical traits/features:
Coronal craniosynostosis, Cryptorchidism, Cutaneous finger syndactyly, Conical incisor, Epicanthus, Erysipelas, Ectopic kidney, Conductive hearing impairment, Malar flattening, Delayed eruption of teeth, Delayed skeletal maturation, Smooth philtrum, Autosomal recessive inheritance, Sensorineural hearing impairment, Oligodontia, Seizure, Pachygyria, Periorbital edema, Pericardial effusion, Pericardial lymphangiectasia, Vesicoureteral reflux, Retrognathia, Pleural effusion, Pleural lymphangiectasia, Broad forehead, Hirsutism, Horseshoe kidney, Hyperactivity, Hydronephrosis, Mild postnatal growth retardation, Hypertelorism, Hypoalbuminemia, Hypoplastic iliac wing, Short foot, Glaucoma, Gingival overgrowth, Depressed nasal bridge, Narrow mouth, Narrow palate, Pectus excavatum, Joint contracture of the hand, Intellectual disability, Intestinal lymphangiectasia, Low-set ears, Lymphedema, Atrial septal defect, Bilateral single transverse palmar creases, Wide nasal bridge, Protein-losing enteropathy

Wie wird jemand getestet? Hennekam Lymphangiectasia-Lymphedema syndrome 1 (HKLLS1)?

Die ersten Tests für das Hennekam-Lymphangiektasie-Lymphödem-Syndrom können mit einem Screening der Gesichtsanalyse über die FDNA Telehealth Telegenetics-Plattform beginnen, mit der die Schlüsselmarker des Syndroms identifiziert und die Notwendigkeit weiterer Tests aufgezeigt werden können. Eine Konsultation mit einem genetischen Berater und dann einem Genetiker wird folgen.

Basierend auf dieser klinischen Konsultation mit einem Genetiker werden die verschiedenen Optionen für Gentests geteilt und die Zustimmung für weitere Tests eingeholt.

Medizinische Informationen zu Hennekam Lymphangiectasia-Lymphedema syndrome 1 (HKLLS1)

Hennekam et al., (1989) described a brother and two sisters, and a cousin from an inbred pedigree, with a syndrome combining intestinal lymphangiectasia, lymphoedema of the limbs and face, and unusual facies. Onset of the lymphoedema was between 1 and 12 years. Affected individuals suffered from recurrent bouts of erysipelas. In other cases oedema has been present at birth, is progressive, and can be asymmetrical. The facies were flat with malar hypoplasia and marked hypertelorism, a flat nasal bridge, a small mouth, delayed eruption of the teeth, which were irregularly spaced, and small ears with narrow external meati and a thick helix. There are prominent lateral palatine ridges. Mild short stature, mental retardation and seizures were also part of the condition. Gabrielli et al., (1991) reported a further affected male who also had gum hypertrophy, supernumerary oral frenula and skin syndactyly of the fingers. There was pachygyria in the parietal region.
Mikelsaar and Lurie (1992) reported a boy with features of Aarskog syndrome and lymphoedema of the legs. There were similarities to Hennekam (1989), but intelligence was normal. Yasunaga et al., (1993) reported a mildly affected boy with the characteristic facial features but with little oedema and again with normal intelligence.
Cormier-Daire et al., (1995) reported a case with craniosynostosis of the coronal sutures and an ectopic kidney. Angle and Hersh (1997) reported an affected girl with the condition. She was also noted to have atretic ear canals, vesicoureteral reflux, rectal prolapse, and syndactyly of 4th and 5th toes. She also had a ventricular septal defect. Erkan et al., (1998) reported a 17 month old Turkish girl with features of the condition. The parents were consanguineous. It is difficult to evaluate the facial features from the clinical photographs however. Huppke et al., (2000) reported two brothers with features of the condition. MRI scans revealed small subcortical hyperintensities in both patients and a large cystic lesion in the younger patient, probably representing an old infarction.
Scarcella et al., (2000) reported two sisters with features of the condition. Unfortunately photographs were not published. Additional complications were hypothyroidism and hypertrophic pyloric stenosis. Both sisters died early within the first year of life. Glaucoma is present in about 10% of cases.
Forzano et al., (2002) reported a possible severely affected case. Four further cases were reported by Al-Gazali et al., (2003).
Bellini et al., (2003) reported a case with nonimmune hydrops fetalis, a congenital chylothorax and pulmonary lymphangiectasia.
Van Balkom et al., (2002) provide an excellent review. The patient reported by Musumeci et al., (2006), had massive genital involvement, including groups of red-violet pseudo-vesicular lesions.
The condition has now been mapped to 18q21 and mutations found in CCBE1 (Alders et al., 2009). Alders et al., (2013) looked at patients with CCB1 mutations and those without - they found no significant clinical differences between the 2 groups. The degree of lymphatic dysplasia was more severe in the mutation positive group.
Alders et al., (2014) looked at patients who were CCB1 negative and using exome sequencing found homozygous mutations in FAT4, the gene responsible for Van Maldergem syndrome. The families testing positive were those of Al-Gazali et al., (2003), Hennekam et al., (1989) and Erkan et al., (1998). DEspite a good deal of overlap, lymphedema is not a feature of Van Maldergem syndrome. Facial pictures shown by these authors of both conditions are convincingly similar.
Note the relatively mild case reported by Frosk et al., (2015). Polydactyly was present (in the case report post-axial, in the discussion pre-axial).

* This information is courtesy of the L M D.
If you find a mistake or would like to contribute additional information, please email us at: [email protected]

Erhalten Sie eine schnellere und genauere Genetische Diagnostik!

Mehr als 250,000 Patienten erfolgreich analysiert!
Warten Sie nicht Jahre auf eine Diagnose. Handeln Sie jetzt und sparen Sie wertvolle Zeit.

Los geht's!

"Unser Weg zu einer Diagnose seltener Krankheiten war eine 5 -jährige Reise, die ich nur als Versuch beschreiben kann, einen Roadtrip ohne Karte zu unternehmen. Wir kannten unseren Ausgangspunkt nicht. Wir kannten unser Ziel nicht. Jetzt haben wir Hoffnung. "


Paula und Bobby
Eltern von Lillie

Was ist FDNA Telehealth?

FDNA Telehealth ist ein führendes Unternehmen für digitale Gesundheit, das einen schnelleren Zugang zu genauen genetischen Analysen bietet.

Mit einer von führenden Genetikern empfohlenen Krankenhaustechnologie verbindet unsere einzigartige Plattform Patienten mit Genexperten, um ihre dringendsten Fragen zu beantworten und eventuelle Bedenken hinsichtlich ihrer Symptome zu klären.

Vorteile von FDNA Telehealth



Unsere Plattform wird derzeit von über 70% der Genetiker verwendet und wurde zur Diagnose von über 250,000 Patienten weltweit eingesetzt.



FDNA Telehealth bietet innerhalb von Minuten eine Gesichtsanalyse und ein Screening, gefolgt von einem schnellen Zugang zu genetischen Beratern und Genetikern.



Unser nahtloser Prozess beginnt mit einer ersten Online-Diagnose durch einen genetischen Berater, gefolgt von Konsultationen mit Genetikern und Gentests.


Genauigkeit & Präzision

Erweiterte Funktionen und Technologien für künstliche Intelligenz (KI) mit einer Genauigkeitsrate von 90% für eine genauere genetische analyse.



Schnellerer Zugang zu genetischen Beratern, Genetikern, Gentests und einer Diagnose. Falls erforderlich, innerhalb von 24 Stunden. Sparen Sie Zeit und Geld.


Privatsphäre & Sicherheit

Wir garantieren den größtmöglichen Schutz aller Bilder und Patienteninformationen. Ihre Daten sind immer sicher und verschlüsselt.

FDNA Telehealth kann Sie einer Diagnose näher bringen.
Vereinbaren Sie innerhalb von 72 Stunden ein Online-Treffen zur genetischen Beratung!